Conference Coverage (AASLD)

Long-Term IFN Cost Effective in Those with Mild HCV

Published in Hepatitis Weekly, December 15th, 1997

Long-term treatment of mild chronic hepatitis C patients with interferon is more cost-effective than short-term treatment, according to a report from Spain presented at the 48th Annual Meeting of the American Association for the Study of Liver Diseases, held November 7-11, 1997 in Chicago, Illinois.

There is increasing evidence that longer treatment boosts sustained responses to interferon, but the cost-effectiveness of a longer treatment schedule is a hotly debated topic.

In this study, researcher M. Buti and colleagues evaluated the cost-effectiveness of the treatment of mild chronic hepatitis C with different schedules of alpha interferon (IFN) in...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (1997-12-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry